Cargando…

Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids

Aristolochic acids (AAs) are human nephrotoxins and carcinogens found in concoctions of Aristolochia plants used in traditional medicinal practices worldwide. Genotoxicity of AAs is associated with the formation of active species catalyzed by metabolic enzymes, the full repertoire of which is unknow...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuno, Yoshiharu, Bonala, Radha, Attaluri, Sivaprasad, Johnson, Francis, Grollman, Arthur P., Sidorenko, Viktoriya S., Oda, Yoshimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899766/
https://www.ncbi.nlm.nih.gov/pubmed/31374128
http://dx.doi.org/10.1002/em.22321
_version_ 1783477203347963904
author Okuno, Yoshiharu
Bonala, Radha
Attaluri, Sivaprasad
Johnson, Francis
Grollman, Arthur P.
Sidorenko, Viktoriya S.
Oda, Yoshimitsu
author_facet Okuno, Yoshiharu
Bonala, Radha
Attaluri, Sivaprasad
Johnson, Francis
Grollman, Arthur P.
Sidorenko, Viktoriya S.
Oda, Yoshimitsu
author_sort Okuno, Yoshiharu
collection PubMed
description Aristolochic acids (AAs) are human nephrotoxins and carcinogens found in concoctions of Aristolochia plants used in traditional medicinal practices worldwide. Genotoxicity of AAs is associated with the formation of active species catalyzed by metabolic enzymes, the full repertoire of which is unknown. Recently, we provided evidence that sulfonation is important for bioactivation of AAs. Here, we employ Salmonella typhimurium umu tester strains expressing human N‐acetyltransferases (NATs) and sulfotransferases (SULTs), to study the role of conjugation reactions in the genotoxicities of N‐hydroxyaristolactams (AL‐I‐NOH and AL‐II‐NOH), metabolites of AA‐I and AA‐II. Both N‐hydroxyaristolactams show stronger genotoxic effects in umu strains expressing human NAT1 and NAT2, than in the parent strain. Additionally, AL‐I‐NOH displays increased genotoxicity in strains expressing human SULT1A1 and SULT1A2, whereas AL‐II‐NOH shows enhanced genotoxicity in SULT1A1/2 and SULT1A3 strains. 2,6‐Dichloro‐4‐nitrophenol, SULTs inhibitor, reduced umuC gene expression induced by N‐hydroxyaristolactams in SULT1A2 strain. N‐hydroxyaristolactams are also mutagenic in parent strains, suggesting that an additional mechanism(s) may contribute to their genotoxicities. Accordingly, using putative SULT substrates and inhibitors, we found that cytosols obtained from human kidney HK‐2 cells activate N‐hydroxyaristolactams in aristolactam‐DNA adducts with the limited involvement of SULTs. Removal of low‐molecular‐weight reactants in the 3.5–10 kDa range inhibits the formation of aristolactam‐DNA by 500‐fold, which could not be prevented by the addition of cofactors for SULTs and NATs. In conclusion, our results demonstrate that the genotoxicities of N‐hydroxyaristolactams depend on the cell type and involve not only sulfonation but also N,O‐acetyltransfer and an additional yet unknown mechanism(s). Environ. Mol. Mutagen. 2019. © 2019 Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-6899766
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68997662019-12-19 Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids Okuno, Yoshiharu Bonala, Radha Attaluri, Sivaprasad Johnson, Francis Grollman, Arthur P. Sidorenko, Viktoriya S. Oda, Yoshimitsu Environ Mol Mutagen Research Articles Aristolochic acids (AAs) are human nephrotoxins and carcinogens found in concoctions of Aristolochia plants used in traditional medicinal practices worldwide. Genotoxicity of AAs is associated with the formation of active species catalyzed by metabolic enzymes, the full repertoire of which is unknown. Recently, we provided evidence that sulfonation is important for bioactivation of AAs. Here, we employ Salmonella typhimurium umu tester strains expressing human N‐acetyltransferases (NATs) and sulfotransferases (SULTs), to study the role of conjugation reactions in the genotoxicities of N‐hydroxyaristolactams (AL‐I‐NOH and AL‐II‐NOH), metabolites of AA‐I and AA‐II. Both N‐hydroxyaristolactams show stronger genotoxic effects in umu strains expressing human NAT1 and NAT2, than in the parent strain. Additionally, AL‐I‐NOH displays increased genotoxicity in strains expressing human SULT1A1 and SULT1A2, whereas AL‐II‐NOH shows enhanced genotoxicity in SULT1A1/2 and SULT1A3 strains. 2,6‐Dichloro‐4‐nitrophenol, SULTs inhibitor, reduced umuC gene expression induced by N‐hydroxyaristolactams in SULT1A2 strain. N‐hydroxyaristolactams are also mutagenic in parent strains, suggesting that an additional mechanism(s) may contribute to their genotoxicities. Accordingly, using putative SULT substrates and inhibitors, we found that cytosols obtained from human kidney HK‐2 cells activate N‐hydroxyaristolactams in aristolactam‐DNA adducts with the limited involvement of SULTs. Removal of low‐molecular‐weight reactants in the 3.5–10 kDa range inhibits the formation of aristolactam‐DNA by 500‐fold, which could not be prevented by the addition of cofactors for SULTs and NATs. In conclusion, our results demonstrate that the genotoxicities of N‐hydroxyaristolactams depend on the cell type and involve not only sulfonation but also N,O‐acetyltransfer and an additional yet unknown mechanism(s). Environ. Mol. Mutagen. 2019. © 2019 Wiley Periodicals, Inc. John Wiley & Sons, Inc. 2019-08-16 2019-12 /pmc/articles/PMC6899766/ /pubmed/31374128 http://dx.doi.org/10.1002/em.22321 Text en © 2019 The Authors. Environmental and Molecular Mutagenesis published by Wiley Periodicals, Inc. on behalf of Environmental Mutagen Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Okuno, Yoshiharu
Bonala, Radha
Attaluri, Sivaprasad
Johnson, Francis
Grollman, Arthur P.
Sidorenko, Viktoriya S.
Oda, Yoshimitsu
Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
title Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
title_full Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
title_fullStr Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
title_full_unstemmed Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
title_short Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
title_sort bioactivation mechanisms of n‐hydroxyaristolactams: nitroreduction metabolites of aristolochic acids
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899766/
https://www.ncbi.nlm.nih.gov/pubmed/31374128
http://dx.doi.org/10.1002/em.22321
work_keys_str_mv AT okunoyoshiharu bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids
AT bonalaradha bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids
AT attalurisivaprasad bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids
AT johnsonfrancis bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids
AT grollmanarthurp bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids
AT sidorenkoviktoriyas bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids
AT odayoshimitsu bioactivationmechanismsofnhydroxyaristolactamsnitroreductionmetabolitesofaristolochicacids